Medical device company AngioDynamics Inc (NASDAQ:ANGO) said on Tuesday that Michael C. Greiner plans to step down as its executive vice president and chief financial officer (CFO).
In conjunction with the change, the company's senior vice president and general counsel Stephen A. Trowbridge will assume the role of interim chief financial officer in addition to his current responsibilities.
However, Greiner will remain with the company to facilitate a smooth transition of duties up to the filing of the second fiscal quarter 10-Q, and has initiated a process to determine a permanent successor.
Additionally, the company is reaffirming its previously issued financial guidance for fiscal year 2020.
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
Implantica's RefluxStop receives US FDA approval
Sectra to provide Education Portal to Loyalist College for medical imaging training
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
Abbott and NACHC launch nationwide Food for Health initiative
Galmed reports positive preclinical results for Aramchol in prostate cancer
Galderma receives EU approval for Restylane Shaype facial shaping injectable
Acarix's CADScor System receives UAE regulatory approval
Amsino receives Vizient contract for enteral syringes
Sisram Medical introduces Titanium Prime treatment concept in Hong Kong SAR